Username or email
BACKGROUND/AIM: Lipitor is a cholesterol-lowering drug and Celebrex is a Cyclooxygenase-2 inhibitor.
Several studies have linked overexpression of the LIM and SH3 domain protein 1 (LASP1) to progression of breast, colon, liver, and bladder cancer.
PURPOSE: Prostate cancer (PCa) patients with biochemical recurrence (BCR) following curative therapy are at higher risk of distant metastasis and cancer-specific death.
Prostate cancer (PCa) is one of the leading causes of cancer deaths in men.
BACKGROUND: Regucalcin (RGN) is a calcium (Ca2+ )-binding protein underexpressed in prostate adenocarcinoma comparatively to non-neoplastic prostate or benign prostate hyperplasia cases.
Denosumab is a monoclonal antibody used for prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors.
An 82-year-old male who presented with the chief complaint of gross hematuria and a history of prostate cancer treated with brachytherapy 6 years previously is described.
Up to 90% of patients with castrate-resistant prostate cancer develop bone metastases, and the majority of these men have received androgen deprivation therapy known to cause bone loss.
The hematopoietic growth factor granulocyte colony-stimulating factor (G-CSF) has a role in proliferation, differentiation and migration of the myeloid lineage and in mobilizing hematopoietic stem and progenitor cells into the bloodstream.
Cordycepin, an active ingredient of the insect fungus Cordyceps spp., shows strong antioxidant and anticancer activities.
Page 1 of 999
Topics on mCRPC, Urology News, OAB, Urinary Catheters, CAUTI, Urology Health, Urinary Leakage, Treating Prostate Cancer, Prostate Cancer Diagnosis, Urology News, Symptoms For Bladder Infection In Men